Postdoctoral positions are available to study molecular mechanisms associated with therapeutic response and resistance in non-small cell lung cancer (NSCLC) in the laboratory of John V. Heymach, MD, PhD at the University of Texas MD Anderson Cancer Center in Houston, TX. The lab is largely interested in the development of rationale treatment strategies for KRAS, EGFR, and HER2 mutant NSCLC with a focus on overcoming resistance to targeted therapies, identifying targetable metabolic adaptations, and enhancing response to immunotherapy. Applicants with experience in any of these areas are encouraged to apply and provide three professional references.
All duties and responsibilities are carried out in compliance with institutional policies, ethical research standards, and applicable federal and state regulations.
*LEARNING OBJECTIVES*
Trainees will perform translational research involving molecular biology approaches (such as CRISPR/Cas technology, Western blotting, ELISA, immuno...